tiprankstipranks
Trending News
More News >
NeoGenomics (NEO)
NASDAQ:NEO
US Market

NeoGenomics (NEO) Financial Statements

Compare
1,919 Followers

NeoGenomics Financial Overview

NeoGenomics's market cap is currently $1.71B. The company's EPS TTM is $0.03; its P/E ratio is -14.45; NeoGenomics is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 660.57M$ 591.64M$ 509.73M$ 484.33M$ 444.45M
Gross Profit$ 290.10M$ 244.60M$ 187.90M$ 187.06M$ 185.89M
Operating Income$ -92.11M$ -107.74M$ -157.62M$ -118.75M$ -13.99M
EBITDA$ -1.51M$ -17.61M$ -82.33M$ -65.40M$ 34.85M
Net Income$ -78.73M$ -87.97M$ -144.25M$ -8.35M$ 4.17M
Balance Sheet
Cash & Short-Term Investments$ 386.84M$ 415.20M$ 437.99M$ 515.39M$ 296.26M
Total Assets$ 1.64B$ 1.68B$ 1.74B$ 1.87B$ 988.33M
Total Debt$ 605.33M$ 611.68M$ 610.93M$ 612.79M$ 218.22M
Net Debt$ 238.32M$ 269.19M$ 347.75M$ 295.96M$ -10.49M
Total Liabilities$ 735.70M$ 739.69M$ 742.01M$ 761.50M$ 294.04M
Stockholders' Equity$ 902.34M$ 941.54M$ 998.02M$ 1.11B$ 694.29M
Cash Flow
Free Cash Flow$ -34.04M$ -30.70M$ -96.88M$ -90.86M$ -27.64M
Operating Cash Flow$ 7.02M$ -1.95M$ -65.99M$ -26.72M$ 1.46M
Investing Cash Flow$ 12.86M$ 76.71M$ 517.00K$ -632.37M$ -159.44M
Financing Cash Flow$ 4.65M$ 4.55M$ 11.83M$ 725.28M$ 235.60M
Currency in USD

NeoGenomics Earnings and Revenue History

NeoGenomics Debt to Assets

NeoGenomics Cash Flow

NeoGenomics Forecast EPS vs Actual EPS